Infectious Diseases News and Research

RSS

Survey data provides insights into how many students are experiencing long COVID

New data from the School Infection Survey (SIS) showed that 1.8% of primary school pupils and 4.8% of secondary school pupils experienced long COVID following their most recent COVID-19 infection (since March 2020).

15 Jun 2022

Synexa Life Sciences Strengthens its Executive Team for Further Growth

Synexa Life Sciences BV, a global leader in specialist biomarker and bioanalysis research services, announces its plans for growth and the strengthening of its executive team.

From Synexa Life Sciences 15 Jun 2022

Syrinx Bioanalytics Acquired by Synexa Life Sciences to Expand Scope of Bioanalysis

Synexa Life Sciences BV, a global leader in specialist biomarker and bioanalysis research services, has today announced that it has acquired Syrinx Bioanalytics, a bioanalytical CRO based in Turku, Finland.

From Synexa Life Sciences 15 Jun 2022

Researchers report the detection of a swine influenza A virus with gene segments of avian H9N2 origin

In a recent study published in Emerging Infectious Diseases, researchers reported natural reassortment of influenza viruses in pigs.

14 Jun 2022

MolGen Showcases Automated High Throughput Laboratory Solutions at the Analytica Fair in Munich

MolGen b.v. of Veenendaal (NL), a global solutions provider of innovative extraction DNA/RNA isolation technology, hardware, systems, consumables and reagents for human diagnostics, agricultural research, and the biotech industry is attending the Analytica Fair, in Munich, on the 21st- 24th of June 2022.

From AgriGenX 14 Jun 2022

Cancer cases and deaths in Africa are expected to double during the next 20 years

Cancer cases and deaths are expected to double in Africa during the next two decades, according to findings from a new study by Penn State College of Medicine researchers.

13 Jun 2022

Study offers a new and unique treatment for AIDS

A new study from Tel Aviv University offers a new and unique treatment for AIDS which may be developed into a vaccine or a one time treatment for patients with HIV.

13 Jun 2022

Covid funding pries open a door to improving air quality in schools

Many U.S. schools were in dire need of upgrades — burdened by leaking pipes, mold, and antiquated heating systems — long before the covid-19 pandemic drew attention to the importance of indoor ventilation in reducing the spread of infectious disease.

13 Jun 2022

Scientists discover novel species of betapolyomavirus in Kenya

A new study published as a pre-proof in the journal Virologica Sinica, is follow-up research to a previous study on the discovery of novel rodent viruses of various RNA viral families in Kenya.

12 Jun 2022

Using artificial intelligence to discover new antivirals against COVID-19 and future pandemics

Research into drugs to treat mosquito-borne flaviviruses such as Zika and dengue as well as COVID-19will benefit from a major funding boost, says a group of international scientists using artificial intelligence to discover new oral antivirals.

10 Jun 2022

Using a harmless amoeba to protect children from dangerous infections

Innovative efforts at the University of Virginia School of Medicine to use a harmless amoeba to protect children from dangerous infections has won critical financial support from The Hartwell Foundation.

10 Jun 2022

A suspected zoonotic SARS-CoV-2 transmission from a cat to a human

Researchers investigated a suspected cat to human transmission of SARS-CoV-2.

10 Jun 2022

Largest-ever series of case studies shows phage therapy’s success in more than half of the patients

The number of reported cases using viruses to treat deadly Mycobacterium infections just went up by a factor of five. In a new study, a team led by researchers from the University of Pittsburgh and the University of California San Diego report 20 new case studies on the use of the experimental treatment, showing the therapy's success in more than half of the patients.

9 Jun 2022

University screening programs gave scientists early insights about omicron’s spread

Omicron was first reported in South Africa on Nov. 24, 2021, and within mere days it was already making the rounds in the United States, spiking SARS-CoV-2 case numbers as it infiltrated every school, restaurant, and family gathering. But when exactly did omicron unseat the delta variant to become dominant? And how quickly did it actually take over?

9 Jun 2022

New technology may enable rapid diagnosis of Ebola virus

A new tool can quickly and reliably identify the presence of Ebola virus in blood samples, according to a study by researchers at Washington University School of Medicine in St. Louis and colleagues at other institutions.

8 Jun 2022

Pregnant people in Sub-Saharan Africa are at higher risk of complications and death from COVID-19

Pregnant people who are hospitalized with COVID-19 in Sub-Saharan Africa are dying at a rate far greater than pregnant people without COVID-19 and non-pregnant people with COVID-19, according to a new multicenter study encompassing six African countries.

8 Jun 2022

The cumulative risk of myocarditis/myopericarditis among global mRNA-1273 recipients

In a recent study, researchers analyzed the incidence of myocarditis among COVID-19 mRNA-1273 vaccinees.

8 Jun 2022

Researchers develop new chemical-only process for creating customized mRNA vaccines

Researchers at Nagoya University in Japan have developed a new chemical-only process that may represent an important breakthrough in creating customized mRNA vaccines for a variety of diseases and allow for the inexpensive preparation of mRNA in large quantities.

8 Jun 2022

Newly identified coronavirus seems to be well established in Sweden's red-backed voles

Researchers from the Zoonosis Science Center at Uppsala University have identified a new coronavirus. Their study of approximately 260 bank voles caught around Grimsö, örebro County, shows that the virus is well established in Sweden's red-backed voles. The finding has been published in the journal Viruses.

8 Jun 2022

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

A medical research team from the University of Hong Kong (HKU) will start a large-scale clinical trial on a new COVID-19 inactivated vaccine (Omicron variant) developed by China National Biotec Group (Sinopharm).

8 Jun 2022

Infectious Diseases News and Research

Survey data provides insights into how many students are experiencing long COVID

Synexa Life Sciences Strengthens its Executive Team for Further Growth

Syrinx Bioanalytics Acquired by Synexa Life Sciences to Expand Scope of Bioanalysis

Researchers report the detection of a swine influenza A virus with gene segments of avian H9N2 origin

MolGen Showcases Automated High Throughput Laboratory Solutions at the Analytica Fair in Munich

Cancer cases and deaths in Africa are expected to double during the next 20 years

Study offers a new and unique treatment for AIDS

Covid funding pries open a door to improving air quality in schools

Scientists discover novel species of betapolyomavirus in Kenya

Using artificial intelligence to discover new antivirals against COVID-19 and future pandemics

Using a harmless amoeba to protect children from dangerous infections

A suspected zoonotic SARS-CoV-2 transmission from a cat to a human

Largest-ever series of case studies shows phage therapy’s success in more than half of the patients

University screening programs gave scientists early insights about omicron’s spread

New technology may enable rapid diagnosis of Ebola virus

Pregnant people in Sub-Saharan Africa are at higher risk of complications and death from COVID-19

The cumulative risk of myocarditis/myopericarditis among global mRNA-1273 recipients

Researchers develop new chemical-only process for creating customized mRNA vaccines

Newly identified coronavirus seems to be well established in Sweden's red-backed voles

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

eBook: Advancing infectious disease vaccine development eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News